Document is current

Any future updates will be listed below

Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: new analyses from the Abatacept study to Gauge Remission and joint damage progression in methotrexate (MTX)-naive patients with Early Erosive rheumatoid arthritis (AGREE)

Crossref DOI link: https://doi.org/10.1186/s13075-015-0671-9

Published Online: 2015-06-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark